• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Topics » Addiction Treatment

Addiction Treatment
Addiction Treatment RSS Feed RSS

Research Update

Can Psilocybin Treat Alcohol Use Disorder?

October 31, 2023
Aniruddha Deka, MD
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Aniruddha Deka, MD. Dr. Deka has no financial relationships with companies related to this material. 

Recent preliminary research reveals that psilocybin helped participants with alcohol use disorder cut back on drinking. Dive in to discover how this psychedelic compound might offer hope for patients who have found other current treatments ineffective.


Read More
Clinical Update

Xylazine: An Emerging Threat in the Opioid Overdose Epidemic

October 31, 2023
Roberto Sanchez, MD and Noah Capurso, MD
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Roberto Sanchez, MD. Addiction psychiatry fellow, Yale University School of Medicine, New Haven, CT.

Noah Capurso, MD, MHS. Assistant professor of psychiatry, Yale University, New Haven, CT; Editor-in-Chief, The Carlat Addiction Treatment Report.

Dr. Sanchez and Dr. Capurso have no financial relationships with companies related to this material.

Xylazine is the latest contaminant being found in the American illicit drug supply. A non-opioid itself, xylazine is usually combined with fentanyl, with which it has synergistic sedative effects. Patients using xylazine can have profound levels of sedation and develop severe peripheral wounds. In this article, we discuss xylazine essentials and cover harm reduction strategies to help keep your patients safe.


Read More
Expert Q&A

When and How Should We Prescribe Benzos?

October 31, 2023
Tae Woo (Ted) Park, MD
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

QA_Benzo-Prescribing_TaeWooPark.JPGTae Woo (Ted) Park, MD. Assistant professor, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA.

Dr. Park has no financial relationships with companies related to this material. 

Despite their risks, benzodiazepines remain a widely prescribed class of medication. In the prescriber right hands, benzodiazepines can help many patients cope with a variety of psychiatric issues. Here, Dr. Park reviews how to evaluate patients prior to starting benzodiazepines and reviews strategies to ensure that prescriptions are done safely.


Read More
Expert Q&A

Deprescribing Benzos: A How-To Guide

October 31, 2023
Audrey Abelleira, PharmD, BCPP
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

QA_Addiction--Prescriptions_Abelleira.jpgAudrey Abelleira, PharmD, BCPP. Clinical pharmacist practitioner, VA Connecticut Healthcare System; clinical instructor, Yale School of Medicine, New Haven, CT.

Dr. Abelleira has no financial relationships with companies related to this material.


Benzodiazepines are widely prescribed but carry significant risks. The best course of action for many patients is to have their benzodiazepine prescription discontinued, but physiologic dependence can make stopping benzodiazepines a big challenge. Dr. Abeillera teaches us how to identify those who might benefit from a taper and covers all the details on how to do it as safely and effectively as possible. 


Read More
EHSStockphoto_Shutterstock_498009256.jpg
Clinical Update

Benzodiazepines: The Basics and Beyond

October 31, 2023
Audrey Abelleira, PharmD, BCPP
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Audrey Abelleira, PharmD, BCPP. Clinical pharmacist practitioner, VA Connecticut Healthcare System; clinical instructor, Yale School of Medicine, New Haven, CT.

Dr. Abelleira has no financial relationships with companies related to this material.

Benzodiazepines vary widely in their pharmacologic properties such as half-life, lipophilicity, and medication interactions. Here, we review the essential pharmacology of the prominent benzodiazepine agents and draw clinical correlates to how these properties translate to patient care.


Read More

CME Post-Test, Revisiting Opioid Use Disorder, CATR, Jul/Aug/Sept 2023

May 29, 2023
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Learning Objectives, Revisiting Opioid Use Disorder, CATR, Jul/Aug/Sept 2023

May 29, 2023
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

After reading these articles, you should be able to…


Read More
Research Update

Intravenous Buprenorphine Microinduction

May 29, 2023
Noah Capurso, MD and Marissa Bayerl, APRN
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Marissa Bayerl, APRN, and Noah Capurso, MD, MHS. Ms. Bayerl and Dr. Capurso have no financial relationships with companies related to this material.

Buprenorphine microinduction can be a useful method of starting BUP induction, however it is not always feasible, particularly in the hospital setting. Here, we discuss the development of an intravenous microinduction protocol that could provide an alternative to the usual sublingual and transdermal routes of administration. 


Read More
Clinical Update

What Psychiatrists Need to Know About Intravenous Drug Use and Endocarditis

May 29, 2023
Kenechukwu Mezue, MD, MSc and Bernardo Lombo, MD, FACC
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Kenechukwu Mezue, MD, MSc. Clinical Fellow in Cardiovascular Medicine, Yale School of Medicine, New Haven, CT.

Bernardo Lombo, MD, FACC. Assistant Professor of Cardiology, Yale School of Medicine, New Haven, CT.

Dr. Mezue and Dr. Lombo have no financial relationships with companies related to this material.

Infective endocarditis (IE) is a dangerous and potentially life-threatening complication of intravenous drug use. This article explores the pathogenesis of IE, key symptoms to recognize, and the crucial steps to take if an infection is suspected. 


Read More
Expert Q&A

Starting Medication for Opioid Use Disorder

May 29, 2023
Gretchen Hermes, MD, PhD
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

CATR-QA2-Headshot_Hermes.jpgGretchen Hermes, MD, PhD. 

Medical Director, APT Foundation; Assistant Professor, Department of Psychiatry, Yale School of Medicine, New Haven, CT.

Dr. Hermes has no financial relationships with companies related to this material.

Dr. Hermes discusses the intricacies of medications for opioid use disorder by outlining the advantages, disadvantages, and side effect profile of each. She will help you choose the best treatment approach for your patients with opioid use disorder by providing a review of relevant literature and gives you language to use in the clinic.


Read More
Previous 1 2 3 4 5 6 7 8 9 … 48 49 Next
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • OUDFB1e_Cover_Binding.png

    Treating Opioid Use Disorder—A Fact Book (2024)

    All the tools you need to assess and treat patients struggling with opioid use disorder. 
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2603816031.jpg
    General Psychiatry

    A Scam for Every Woman, Child, and Man: Part 2

    1 in 3 Americans were victims of online scams in the past year. Even when you know your patient is being scammed, it is hard to pull them out. We speak with Cathy Wilson about...
    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.